Cargando…
Monitoring T Cells Responses Mounted by Therapeutic Cancer Vaccines
With the regulatory approval of Provenge and Talimogene laherparepvec (T-VEC) for the treatment of metastatic prostate cancer and advanced melanoma respectively, and other promising clinical trials outcomes, cancer vaccine is gaining prominence as a cancer therapeutic agent. Cancer vaccine works to...
Autores principales: | Lim, Kue Peng, Zainal, Nur Syafinaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082312/ https://www.ncbi.nlm.nih.gov/pubmed/33937323 http://dx.doi.org/10.3389/fmolb.2021.623475 |
Ejemplares similares
-
Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring
por: Shah, Jay V., et al.
Publicado: (2020) -
Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways
por: Suraweera, Amila, et al.
Publicado: (2022) -
A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer
por: Liu, Jie, et al.
Publicado: (2022) -
Ado-tratuzumab emtansine beyond breast cancer: therapeutic role of targeting other HER2-positive cancers
por: Zheng, Yang, et al.
Publicado: (2023) -
Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer
por: Liu, Bangquan, et al.
Publicado: (2022)